论文部分内容阅读
目的:探讨胺碘酮在冠心病合并心律失常中的治疗效果与价值。方法:选取我院收治的80例冠心病合并心律失常患者作为研究对象,随机分为两组,观察组和对照组妇女各40例,对照组采用常规性的治疗方法。观察组在常规治疗的基础上,静脉注射胺碘酮。比较两组患者的治疗效果。结果:观察组的总有效率为92.5%,对照组的总有效率为80%。观察组与对照组相比,治疗效果更好,差异显著,P<0.05,具有统计学意义。其次,两组患者的室性早搏总数均增加,左室射血分数均上升。观察组与对照组相比,改善幅度更大。P<0.05,具有统计学意义。结论:在冠心病合并心律失常治疗中,给予常规治疗外,同时静脉注射胺碘酮,改善了患者的症状,促进了患者的预后,取得了良好的治疗效果。值得在临床上推广。
Objective: To investigate the efficacy and value of amiodarone in the treatment of coronary heart disease complicated with arrhythmia. Methods: Eighty patients with coronary heart disease complicated with arrhythmia admitted to our hospital were selected as study subjects and randomly divided into two groups. The observation group and the control group included 40 women each. The control group received routine treatment. Observation group on the basis of conventional treatment, intravenous amiodarone. The treatment effect of two groups of patients was compared. Results: The total effective rate was 92.5% in the observation group and 80% in the control group. The observation group compared with the control group, the treatment effect is better, the difference was significant, P <0.05, with statistical significance. Second, the total number of premature ventricular contractions in both groups increased, and left ventricular ejection fraction increased. The observation group compared with the control group, a greater improvement. P <0.05, with statistical significance. Conclusion: In the treatment of coronary heart disease with arrhythmia, given conventional treatment, while intravenous amiodarone, improve the patient’s symptoms and promote the prognosis of patients and achieved good therapeutic effect. Worthy of clinical promotion.